Lonza India plans to double its turnover by 2024
Lonza is a global integrated solutions provider for pharma, consumer healthcare and nutrition segments. Deepak Sood, MD, Lonza…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Lonza
Lonza expands its bioconjugation facility in Visp, Switzerland
Lonza’s expansion will meet development, manufacturing needs of pharma and biotech companies developing a new generation of…
Vcaps Plus Capsules: The gold standard in HPMC capsules
A special report from Lonza Pharma and Biotech presenting a comparative human in-vivo study on the impact of dissolution rate on…
Lonza and bluebird bio establish commercial manufacturing agreement for Lenti-D and LentiGlobin drug…
The agreement provides bluebird bio with a path to commercial supply including dedicated production suites within Lonza’s…
Rodolfo Savitzky appointed as new CFO for Lonza Group
Savitzky had joined Lonza in March 2015 as Head of Finance & Controlling for the pharma and biotech segment
Lonza acquires NZ-based research-focused chemical company Zelam
It will allow Lonza to leverage Zelam’s existing agrochemical business for registration and sales into other global regions
Lonza…
Lonza announces additional long-term agreement with Alexion
This agreement will supplement existing production of Alexion products at multiple Lonza facilities